Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization

Receipt of an updated COVID-19 vaccine dose provided increased protection against COVID-19–associated emergency department and urgent care encounters and hospitalization compared with no receipt of an updated vaccine dose among immunocompetent U.S. adults during a period of multiple cocirculating SARS-CoV-2 Omicron lineages.

Next
Next

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2024